Avadel Pharma (AVDL) Misses Q4 EPS by 4c

Avadel Pharma (NASDAQ: AVDL) reported Q4 EPS of ($0.32), $0.04 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $19.45 million versus the consensus estimate of $18.21 million.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• GE Vernova (GEV) PT Raised to $1,185 at Jefferies
• Macy's (M) Stock: Street Underestimates Earnings Pressure From Share Loss, Says Analyst